Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jun 2 2021

Full Issue

Perspectives: While You Were Distracted, Big Pharma Raised Prices

Read recent commentaries about drug-cost issues.

MarketWatch: Inflation In Drug Prices Is Soaring And It’s Time To Break Big Pharma’s Grip On Our Health 

In the thick of the coronavirus pandemic, while receiving billions in taxpayer dollars to help develop critically needed vaccines, the biggest pharmaceutical corporations hoped no one would notice that they were raising prices on more than 800 prescription medicines that families rely on for their health and wellbeing. That’s nothing new: between 2007 and 2018, drug corporations increased list prices on prescription drugs by 160%. As a result, Americans today pay two- to four times more for prescription drugs than people in other countries for the same medicines. That’s why Democrats and Republicans alike have campaigned for years to lower drug prices, because the cost is simply unaffordable for too many. (Margarida Jorge, 5/29)

Star-Ledger: A Plan For New Jersey Residents To Pay Less For Their Prescriptions 

The COVID-19 pandemic has caused a loss of focus on rising pharmaceutical drug prices. The industry bringing forth vaccines to protect our health and facilitate a return to a more favorable quality of life is laudable. However, in the first six months of 2020, when the pandemic was raging, pharmaceutical companies increased prices on 245 drugs according to a report by Patients for Affordable Drugs. The costs of pharmaceuticals have become unsustainable. (John F. McKeon, 5/30)

State Journal-Register: How Illinois Saved Money Using The Private Sector To Purchase Drugs

A sizable part of the Illinois budget provides medical care for its residents who do not have the means to purchase health insurance on their own. While reducing this cost without sacrificing the quality of care can be difficult and politically contentious, the state recently managed to save tens of millions of dollars simply by employing the private sector to help negotiate prices for a new lifesaving drug. Twenty percent of Illinois’ population is enrolled in Medicaid. Last year the state spent nearly $1 billion for prescription drugs, a good portion of the state’s $43 billion budget.  (Ike Brannon and Tony Lo Sasso, 5/30)

Atlanta Journal-Constitution: Too Little, Too Late On At-Home COVID Tests

The Food and Drug Administration recently approved two over-the-counter, at-home rapid coronavirus tests. Harvard epidemiologist Dr. Michael Mina called this development “a major advance.” He’s right. But the FDA should have reached this milestone months ago. Regulators dawdled, and thousands of people died. Public health experts have been calling for at-home COVID-19 tests since the early days of the pandemic. With more testing, more people would know they had the virus, stayed home, and slowed the virus’s spread. (Sally C. Pipes, 6/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF